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The benefits of radiosurgery for cavernous malformations are difficult to assess because of the unclear natural his­
tory of this vascular lesion, the inability to image malformation vessels, and the lack of an imaging technique that 
defines “cure.” The authors selected for radiosurgery 47 patients who harbored a hemorrhagic malformation in a crit­
ical intraparenchymal location remote from a pial or ependymal surface. Of these, 44 patients had experienced at least 
two hemorrhages before radiosurgery. The mean patient age was 39 years; six patients had previously undergone 
attempted surgical removal. The malformation was located in the pons/midbrain in 24 cases, the medulla in three, the 
thalamus in nine, the basal ganglia in three, deep in a parietal lobe in four, and deep in a temporal lobe in four. Patients 
had sustained initial hemorrhages from 0.5 to 12 years prior to radiosurgery (mean 4.12 years). In these patients, who 
were not typical of the majority of patients with cavernous malformations, there were 109 bleeds before radiosurgery 
in 193 prior observation-years, for a 56.5% annual hemorrhage rate (including the first hemorrhage), or an annual rate 
of 32% subsequent to the first hemorrhage.
The mean follow-up period after radiosurgery was 3.6 years (range 0.33-6.4 years). The proportion of patients with 
hemorrhage after radiosurgery was significantly reduced (p <  0.0001), as was the mean number of hemorrhages per 
patient (p = 0.00004). In the first 2 years after radiosurgery, there were seven bleeds in 80 observation-years (8.8% 
annual hemorrhage rate). In the 2- to 6-year interval after radiosurgery, the annual rate decreased to 1.1% (one bleed). 
After radiosurgery, 12 patients (26%) sustained neurological worsening that correlated with imaging changes. In eight 
patients these deficits were temporary; two underwent surgical resection and died. Two patients had new permanent 
deficits (4%). A significant reduction was observed in the hemorrhage rate after radiosurgery in patients who had deep 
hemorrhagic cavernous malformations, especially after a 2-year latency interval. This evidence provides further sup­
port to the belief that radiosurgery is an effective strategy for cavernous malformations, especially when located with­
in the parenchyma of the brainstem or diencephalon.
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Fe w  concepts evoke as much controversy in the use of radiosurgical techniques as the management of brain cavernous (angiographically occult) malformations. 
In 1990, we reported our preliminary experience with 
radiosurgery in 24 patients to introduce our patient selec­
tion criteria, technique of treatment planning and dose 
selection, and initial short-term results.10 At that time, few 
reports of successful microsurgical resection in patient 
series were available. Thus, for patients who had sustained 
multiple brain hemorrhages and harbored a malformation 
in a critical brain location, the options were limited, and 
such cases were generally managed with further conser­
vative observation. We hypothesized that the vessels of 
angiographically occult vascular malformations (we
believe most are cavernous malformations) would 
respond in a similar fashion to true arteriovenous malfor­
mations (AVMs) which had been proven to benefit from 
radiosurgery.14 We anticipated that by using accurate ste­
reotactic high-resolution imaging, we would be able to re­
duce the hemorrhage risk in individual patients, after a 
latency interval.2
Because there was no imaging test to confirm oblitera­
tion in such angiographically occult lesions, we knew that 
clinical benefit would be confirmed by observing a reduc­
tion in hemorrhage rate over time and a low risk of com­
plications. In this report we compare the observed hemor­
rhage rate before irradiation to the rate observed after 
radiosurgery.
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TABLE 1
Characteristics o f  47 cavernous malformations 
selected fo r  radiosurgery













Clinical Material and Methods
Between 1987 and 1994, we performed stereotactic ra­
diosurgery on 47 patients with cavernous malformations 
at the University of Pittsburgh. The mean patient age was 
39 years. There were 24 males and 23 females. The mean 
number of hemorrhages before radiosurgery was 2.3 per 
patient. Forty-four patients had suffered at least two hem­
orrhages (range two-five); three patients with malforma­
tions in critical brain locations had sustained only one 
documented hemorrhage. Six patients had undergone at­
tempts at surgical resection of their malformation; two had 
received a biopsy. All patients had magnetic resonance 
(MR) imaging and angiography before radiosurgery. The 
MR appearance was typical of a cavernous malformation 
in each patient,15 but no abnormality was identified on
TABLE 2
Cavernous malformation radiosurgery dose planning
Parameter Mean Range
malformation volume (ml) 2.1 0.2-8.1
no. of isocenters 2.1 1-8
margin dose (Gy) 16 10-20
maximum dose (Gy) 32 20-40
angiography. The brain locations of cavernous malforma­
tions in this series are shown in Table 1. No patient had a 
seizure disorder.
Our technique for cavernous malformation radiosur­
gery has been reported previously,10 but will be described 
briefly here. After application of the Leksell model G ste­
reotactic frame (Elekta Instruments, Atlanta, GA) under 
local scalp infiltration anesthesia and mild oral or intra­
venous sedation, a stereotactic scan is performed. Com­
puterized tomography (CT) was used for planning in all 
patients prior to 1990. Patients treated from 1988 through 
1990 had both CT and MR imaging. Since 1990, only 
stereotactic MR has been performed. After a sagittal 
short-repetition time (TR) scout image acquisition, axial 
short- and long-TR images are obtained at 3-mm image 
intervals. In patients with small malformations (less than 
15 mm in diameter), a volume acquisition is performed 
with images at 1-mm intervals. After the administration of 
a contrast agent, repeat axial and coronal short-TR images 
are obtained. The dimensions of the malformation are 
measured in three planes. Although we acknowledge that 
definition of the cavernous malformation nidus is diffi­
cult, we define the malformation as the region character­
ized by mixed signal change within an outer hemosiderin
Fig. 1. Magnetic resonance images at the time of radiosurgery in a 33-year-old man with a right thalamic cavernous 
malformation. He had sustained two prior hemorrhages, each over 2.5 cm in diameter. The lesion is well identified on 
both short- and long-TR images. a and b: Coronal and axial views used for isodose planning. c: The margin isodose 
(50%, black arrow) for radiosurgery was kept within the peripheral hemosiderin ring (white arrows, a). Radiosurgery 
was performed with three 8-mm isocenters, and a maximum dose of 32 Gy was used. The 20% and 50% isodose lines 
are shown.
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ring, typified by low signal intensity. Hematoma eccentric 
from the malformation is excluded from dose planning. 
Dose planning is performed at a computer workstation. 
Single- or multiple-isocenter plans are then used to con­
struct a conformal irradiation volume for the cavernous 
malformation margin (Fig. 1). In all patients in this series, 
the 50% isodose or greater was used for the margin. Dose 
planning and target selection was performed by a neu­
rosurgeon, radiation oncologist, and medical physicist. 
Selection of the dose for radiosurgery was dependent on 
malformation volume;10 we reduced the dose below that 
advocated for an AVM of similar volume. Radiosurgery 
was performed with a 201-source cobalt-60 gamma unit 
(Elekta Instruments). The volume of the malformation 
was determined on the computer workstation as the sum 
of the voxels within the isodose used to envelop the mal­
formation margin. Malformation volumes and dose-se- 
lection parameters are detailed in Table 2. After radiosur­
gery, all patients received 40 mg methylprednisolone 
intravenously. Patients were discharged from the hospital 
either the same afternoon or the next morning (range of 
hospital stay 6-24 hours).
Follow-up imaging studies were requested at 6-month 
intervals for the first 2 years after radiosurgery, yearly 
thereafter for two years, and then biennially. Clinical fol­
low-up data were obtained from the patients and their 
referring physicians when they lived at a distance from 
Pittsburgh. Results were analyzed by an independent bio­
epidemiologist (J.R.K.).
Hemorrhage rates were calculated as: rate = total num­
ber of bleeds in all patients/total number of patient-years 
in the observation period. The proportion of patients who 
sustained a hemorrhage in observation periods before and 
after radiosurgery was compared using a McNemar chi- 
square test (for paired data). The number of hemorrhages 
per patient before and after radiosurgery was compared 
using a paired t-test. Patients were censored at the time of 
death or surgical resection; if a bleed was the cause of the 
death or resection, it was recorded as such.
Results
Risk o f Hemorrhage
The occurrence of symptomatic hemorrhages before 
and after stereotactic radiosurgery is depicted in Fig. 2. In 
all, 47 patients were followed through the pre- and postra­
diosurgery observation periods.
Preradiosurgery Hemorrhage Rates
Prior to radiosurgery, there were 193 patient-years of 
observation in the 47 patients (calculated from date of first 
hemorrhage in each patient); 109 hemorrhages occurred in 
these patients (mean 2.34 bleeds per patient). Forty-four 
patients sustained at least two hemorrhages, and three pa­
tients had one hemorrhage. The mean observation interval 
before radiosurgery was 4.12 years (range 0.5-12 years). 
The occurrence of 109 bleeds in the 193 years of observa­
tion led to an annual hemorrhage rate of 56.5%.
Another approach to the calculation of the rate of hem­
orrhage is to use the first bleed as an indicator that the pa­
tient has a malformation and count that as time zero for
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Fig. 2. Timeline (years) before and after gamma knife radio­
surgery (GK) for all 47 patients with cavernous malformations. 
Each black dot represents the occurrence of a hemorrhage and dur­
ing which year, either before or after treatment. OR signifies resec­
tion of the malformation. An x denotes death of the patient, either 
from unrelated causes or after surgery. An arrow  indicates that the 
patient has remained hemorrhage-free.
that patient’s pretreatment observation. If this is done and 
the first hemorrhage excluded, there are then 62 bleeds in 
193 observation years for an annual rate of 32%. Thus, in 
the period of hemorrhagic activity before treatment, these 
patients had a calculated risk of over 30% for sustaining a 
symptomatic hemorrhage each year. It can be argued that, 
because the malformation was present since birth, the pre­
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treatment observation period should be the patient’s life­
time. This would result in an annual hemorrhage rate of 
5.9% (109 bleeds in 1833 years of observation).
Postradiosurgery Hemorrhage Rates
The posttreatment observation period was from the time 
of radiosurgery until last follow-up examination, surgery, 
or death. The follow-up period after radiosurgery varied 
from 0.33 to 6.4 years (mean 3.6 years). The shortest 
follow-up time (0.33 years) was in a single patient who 
sustained a hemorrhage shortly after radiosurgery and un­
derwent malformation resection (the hemorrhage provid­
ed a resection corridor through the floor of the fourth ven­
tricle). After irradiation, a total of eight hemorrhages were 
observed in 169 patient-years of observation. Because of 
an estimated 2-year latency interval for maximum vascu­
lar effects, we stratified results from 0 to 2 years and from 
2 to 6 years after treatment. From 0 to 2 years after radio­
surgery, seven bleeds in 80 observation years were found 
(annual hemorrhage rate of 8.8%). From 2 to 6 years, only 
one bleed in 89 observation years was found, for an annu­
al hemorrhage rate of 1.1%.
If the first bleed in each patient is ignored and serves 
simply to identify the beginning of the observation period 
for that patient, then 44 of the 47 patients had at least 
one hemorrhage before radiosurgery. Only six of these 47 
patients bled after radiosurgery (McNemar chi-square = 
36, p <  0.0001). The mean number of hemorrhages per 
patient was also compared before and after radiosur­
gery, and a significant reduction was identified (t = 4.51, 
p = 0.00004).
Morbidity o f  Radiosurgery
Within 3 to 18 months after irradiation, 12 patients 
(26%) developed new neurological deficits associated 
with parenchymal imaging changes (regions of increased 
signal on long-TR images surrounding the lesion) on MR 
imaging. Associated symptoms were location-dependent. 
Two patients with thalamic cavernous malformations de­
veloped hemiparesis requiring prolonged oral corticoste­
roid use before recovery. In eight patients, these deficits 
were temporary with full recovery. In two patients, the 
malformation was resected. Thus, two patients (4%) were 
left with permanent neurological deficits from radiosur­
gery; both patients remain functional with Karnofsky per­
formance scores of 80 and 90, respectively.
Two patients died of causes unrelated to their cavernous 
malformation. In an additional two patients, an attempt 
at resection of the malformation was made at a time of 
increased neurological symptoms (one from related 
edema and one from hydrocephalus). One patient had a 
cavernous malformation within the midbrain and the other 
at the pontomedullary junction. Both patients died after 
attempted resection. In summary, a total of six patients 
had surgical resection subsequent to radiosurgery. In 
this group, four patients are doing well (three with brain­
stem malformations and one with a thalamic lesion) and 
two died.
Imaging Changes
Serial MR studies were performed initially at 6-month
intervals for the first 2 years, then yearly. Twelve patients 
had increased long-TR signal changes associated with 
neurological symptoms, as mentioned above. Ten patients 
had a reduction in the size of their malformation, which 
represented either a treatment-related effect on the mal­
formation’s vessels or continued resorption of hematoma/ 
microhemorrhage. In all other patients, the imaging ap­
pearance of the malformation remained unchanged.
Discussion
Reduction in Hemorrhage Risk
At a maximum follow-up time now past 6 years, 41 
patients (87%) with high-risk cavernous malformations 
remained hemorrhage-free after radiosurgery. All six pa­
tients who sustained a hemorrhage after irradiation did 
so within 2 years of the procedure. One sustained three 
hemorrhages within 3 years and underwent resection. 
Although the mean follow-up period in this study after 
radiosurgery was only 3.6 years, 22 patients were fol­
lowed for more than 4 years and none had a rehemor­
rhage. We submit that a latency interval for protection 
from repeat hemorrhage within the first 2 years appears 
reasonable.
Within the first 2 years after radiosurgery (total of 
80 observation years), seven hemorrhages occurred. This 
equaled an 8.8% annual hemorrhage rate. After the initial
2 years following radiosurgery, only one bleed occurred in 
the next 89 years of total observation, a reduction in the 
annual hemorrhage rate to 1.1%. This reduced rate now 
approximated that identified in natural history studies of 
cavernous malformation.317 Such a latency interval for 
radiation effect would be similar to that expected in AVM 
radiosurgery.14 The total length of the latency interval (the 
time required for maximum therapeutic effect) is not 
known, although if it were to parallel the AVM response, 
we would estimate this time to be within 3.5 years of irra­
diation.
In a separate study of 122 patients managed conser­
vatively and prospectively followed for a mean of 34 
months, we found an overall annual symptomatic hemor­
rhage risk of 2.6%. However, patients with at least one 
prior hemorrhage had an annual risk of 4.5%, and patients 
without prior clinical hemorrhage, a 0.6% risk.12 These 
hemorrhage risks are lower than in the patients we select­
ed for radiosurgery, who had a mean of 2.3 hemorrhages 
prior to irradiation. Thus, the late, reduced hemorrhage 
risk of our radiosurgery patients (1.1%) approaches the 
low risk we identified in that study for nonhemorrhagic 
cavernous malformations. We stress that the patients se­
lected in this study for radiosurgery were not typical of the 
majority of patients with cerebral cavernous malforma­
tions in that they were considered to be poor candidates 
for microsurgery and because they had sustained multiple 
hemorrhages. Prior reports indicate that for patients with­
out prior hemorrhage, the annual hemorrhage rate is be­
low 1%.3’17
We cannot guarantee complete obliteration of a cav­
ernous malformation just because the patient survived 
several years after treatment without sustaining a new 
hemorrhage. There is currently no neurodiagnostic test 
that can confirm such a curative result. Although patients
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may be encouraged by a reduction in hemorrhage risk, 
they cannot be told that this risk is eliminated. Perhaps in 
the future imaging tools that detect blood volume within 
the malformation, rather than blood flow, will prove valu­
able. For example, metabolic imaging studies such as 
positron emission tomography or single-photon emission 
CT may identify the blood volume of the lesion before 
radiosurgery. A subsequent reduction after radiosurgery 
would support the concept of obliteration. Unfortunately, 
the small volume of many of these malformations make 
them poorly resolved by currently available techniques. 
For the present, the clinical course before and after radio­
surgery remains the most important tool we have to eval­
uate these patients.
The Rationale fo r  Radiosurgery
Current neurosurgical strategies for cavernous malfor­
mations are significantly different from those reported 
prior to 1988. At that time, the successful resection of 
deeply located cavernous malformations associated with 
low morbidity was reported in anecdotal form only.6-20-25-26 
The hazards of operating within the brainstem or dien­
cephalon for these lesions were stressed by several au­
thors.1925 Lacking appreciable surgical experience with 
safe, successful removal of these lesions, we managed 
most patients conservatively even after hemorrhage. Thus, 
in 1988 we began our use of stereotactic radiosurgery as 
an alternative management approach to hemorrhagic cav­
ernous malformations. We recommended radiosurgery on­
ly for intraparenchymal malformations in deep brain lo­
cations where the risks of surgical resection were thought 
to be excessive. Referred patients who were clinically sta­
ble and who had sustained only one hemorrhage were 
not accepted as candidates for radiosurgery. Rather, we 
recommended either microsurgical resection (depending 
upon location) or further conservative observation. The 
latter patients were entered into a separate prospective 
natural history study.
The Importance o f Neuroimaging
Clearly, the introduction of MR imaging led to a signif­
icant increase in the diagnosis of intracerebral cavernous 
malformations. We recognized that high-resolution MR 
imaging provided graphic anatomical and vascular detail 
that enhanced microsurgical results; it could also identify 
malformations that presented on a pial or ependymal sur­
face, thereby making them suitable for resection.
It is likely that the majority of angiographically occult 
vascular malformations are cavernous-type malforma- 
tions.18 We performed high-resolution subtraction angiog­
raphy to determine whether each vascular malformation 
was truly angiographically occult. Venous angiomas iden­
tified on either MR images or angiograms were not 
accepted for radiosurgery.9 We and others16 believe that 
some patients have cavernous malformations in associa­
tion with venous malformations. In the clinical context of 
observed hemorrhage, it is most likely that the bleed was 
from the cavernous malformation.16 We performed radio­
surgery on one patient who had a thalamic cavernous mal­
formation (and adjacent venous malformation) with two 
hemorrhages.
During the 7-year interval of our radiosurgery study, 
several publications reported the successful and relatively 
safe removal of deep-seated cavernous malformations. 
Kashiwagi and colleagues8 reported four patients treated 
with surgical resection of their brainstem cavernous 
malformations; only one had additional morbidity (from 
hydrocephalus). Zimmerman, et al.,21 described 24 pa­
tients with brainstem cavernous malformations, 16 of 
whom underwent resection. Although four patients had 
new deficits after surgery, all were transient. Twelve pa­
tients were the same or improved in the immediate post­
operative period, but one died 6 months after resection 
from shunt infection and sepsis. Seven of the eight pa­
tients who were managed conservatively remained stable, 
although one died from rehemorrhage.
Bertalanffy, et al.,1 reported results on 26 patients treat­
ed with microsurgery for deep-seated cavernous malfor­
mations. Eighteen patients underwent surgery because of 
progressive neurological deficits; 15 of whom had sus­
tained a hemorrhage. Successful total resection without 
morbidity was achieved in 11 patients and seven patients 
had new deficits after surgery. An additional eight patients 
suffered major deficits, five of these with lesions of the 
basal ganglia, thalamus, or insula. Based on their unsatis­
factory results, these authors questioned whether the indi­
cations for deep cavernous malformation surgery should 
be limited.1 Other groups, however, presenting small pa­
tient series, emphasized the importance of intraoperative 
localization followed by meticulous microsurgical tech­
nique to attain a good surgical outcome in deep brain loca- 
tions.4’5’713’21-24 These reports provided evidence that, at 
experienced centers, many cavernous malformations can 
be totally resected with low risk of permanent morbidity, 
provided that the malformation or hematoma presents on 
a pial or ependymal surface (brainstem or thalamus) or is 
located in a noncritical region.
Potential Vascular Effects o f  Radiosurgery
Although the vascular obliterative response of a true 
AVM after radiosurgery is well documented, we speculate 
that the vessels of a cavernous malformation may respond 
similarly to high, single-session doses of irradiation. This 
response might consist of endothelial cell proliferation, 
vessel wall hyalinization and thickening, and eventual 
luminal closure. A latency interval of 2 to 3 years might 
be necessary to achieve this result. All of our patients are 
warned of the potential risk of hemorrhage during the ini­
tial years after radiosurgery before the maximum oblitera- 
tive response may have occurred. However, because there 
is no imaging test to confirm such obliteration, patients 
and their referring physicians must be aware that the 
absence of further hemorrhage is an indication, and not 
a confirmation, that a positive response has occurred. 
Clearly, the absence of hemorrhage after radiosurgery 
may only be part of the natural history of that individual 
patient’s cavernous malformation. In our comparison of 
the proportion of patients with a hemorrhage before radio­
surgery with that following irradiation, we found a signif­
icant reduction (p <  0.001) up to 6 years. This statistical 
analysis assumes that the natural history of the lesions (if
The Role o f Microsurgery
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left untreated) in this study would have been to continue 
to have a high risk of bleeding in the absence of any other 
intervening factors. However, we must admit that the nat­
ural history in individual patients is unknown and may be 
composed of a brief interval of accelerated risk of hemor­
rhage followed by a more prolonged period with a re­
duced risk of hemorrhage.
Morbidity o f  Radiosurgery
In our 1990 report, we provided dose-selection guide­
lines for cavernous malformation radiosurgery.10 These 
guidelines represented a reduction in the dose that would 
be administered to an AVM of similar volume. The risk of 
radiosurgery for cavernous malformations may be greater 
than the risks for other pathological entities. The critical 
location of these malformations may be an explanation for 
the observed increased morbidity as compared to our gen­
eral experience with AVMs or tumors. In comparison to 
our brainstem AVM series (for which we found a tempo­
rary morbidity rate of 16%),11 the 26% temporary morbid­
ity rate in this cavernous malformation series was higher. 
Whether the increased risk is a function of the lesion itself 
or the altered tolerance of the surrounding brain tissue 
remains to be shown.
The reduction in the prescribed radiation dose for cav­
ernous malformations, as suggested in our earlier report, 
was evaluated in the 23 patients managed subsequently. 
Despite the dose reduction, we were not able to reduce 
the incidence of complications; however, the severity of 
complications was reduced. In the later group, most new 
symptoms consisted of temporary cranial neuropathy or 
mild ataxia whereas, in the initial group, larger regions of 
altered long-TR signal change on MR images were asso­
ciated with hemiparesis, hemisensory deficits, and cranial 
neuropathies. We do not believe that a further reduction 
in dose is necessary, as this could reduce the obliterative 
response.
Conclusions
In this group of patients with hemorrhagic cavernous 
malformations located in critical brain regions that were 
thought to pose an excessive risk for microsurgical resec­
tion, radiosurgery using the gamma unit appears to reduce 
the rate of hemorrhage, especially after a 2-year latency 
interval. Only a prospective randomized trial of micro­
surgery versus radiosurgery will answer questions as to 
the efficacy and necessity of these different approaches. 
The morbidity associated with this treatment strategy for 
cavernous malformations, the majority of which were lo­
cated in the brainstem or diencephalon, was not negligi­
ble; however, in most patients these delayed effects were 
temporary. Although we have shown for the first time the 
benefits of radiosurgery for cavernous malformations, we 
do not advocate its use for minimally symptomatic lesions 
or for patients who would be better managed with open 
surgical resection.
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